{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HCG", "query": { "intervention": "HCG" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 170, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HCG&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T09:22:37.144Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06178224", "title": "Determining Beta-hCG Levels in Patients Through Alternative Sample Types", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy Related", "Abortion" ], "interventions": [], "intervention_types": [], "sponsor": "Simple HealthKit", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 40, "start_date": "2022-10-11", "completion_date": "2023-06-23", "has_results": false, "last_update_posted_date": "2023-12-20", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06178224" }, { "nct_id": "NCT05123040", "title": "Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute-graft-versus-host Disease" ], "interventions": [ { "name": "Ruxolitinib 10 MG Oral Tablet", "type": "DRUG" }, { "name": "hCG", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 10, "start_date": "2023-06-05", "completion_date": "2026-02-27", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05123040" }, { "nct_id": "NCT03122145", "title": "Normal Breathing and Swallowing in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Capsaicin", "type": "DRUG" }, { "name": "Videofluoroscopic swallow study", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 49, "start_date": "2017-05-23", "completion_date": "2019-02-28", "has_results": true, "last_update_posted_date": "2021-01-14", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03122145" }, { "nct_id": "NCT04303169", "title": "Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Vibostolimab", "type": "BIOLOGICAL" }, { "name": "Gebasaxturev", "type": "BIOLOGICAL" }, { "name": "MK-4830", "type": "BIOLOGICAL" }, { "name": "Favezelimab + Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "ATRA", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 146, "start_date": "2020-06-26", "completion_date": "2025-09-24", "has_results": true, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 11, "location_summary": "Los Angeles, California • Santa Monica, California • Aurora, Colorado + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04303169" }, { "nct_id": "NCT04445025", "title": "Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Infertility", "Endometriosis" ], "interventions": [ { "name": "Elagolix 200 MG", "type": "DRUG" }, { "name": "Leuprolide Acetate 3.75 MG/ML", "type": "DRUG" }, { "name": "Lab work", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Colorado Center for Reproductive Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "42 Years", "sex": "FEMALE", "summary": "21 Years to 42 Years · Female only" }, "enrollment_count": 30, "start_date": "2020-09-01", "completion_date": "2024-12-30", "has_results": false, "last_update_posted_date": "2025-02-20", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Lone Tree, Colorado", "locations": [ { "city": "Lone Tree", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04445025" }, { "nct_id": "NCT06324929", "title": "Optimizing a Digital AEP Risk Intervention With Native Women and Communities", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Exposed Pregnancy", "Unplanned Pregnancy", "Alcohol Use, Unspecified", "Contraception Use", "Sexual Behavior" ], "interventions": [ { "name": "CARRII Native Rapid Pilot Testing", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "18 Years to 44 Years · Female only" }, "enrollment_count": 407, "start_date": "2024-05-16", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06324929" }, { "nct_id": "NCT01815138", "title": "Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ovarian Hyperstimulation Syndrome" ], "interventions": [ { "name": "hCG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UConn Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "FEMALE", "summary": "18 Years to 39 Years · Female only" }, "enrollment_count": 89, "start_date": "2013-03", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2018-10-26", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01815138" }, { "nct_id": "NCT07481370", "title": "Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oligospermia", "Azoospermia, Nonobstructive", "Infertility" ], "interventions": [ { "name": "isotretinoin", "type": "DRUG" }, { "name": "Human chorionic gonadotrophin (hCG)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "19 Years to 50 Years · Male only" }, "enrollment_count": 100, "start_date": "2026-04-13", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07481370" }, { "nct_id": "NCT00232154", "title": "A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sinusitis" ], "interventions": [ { "name": "Zithromax™ (azithromycin) 500mg tablets", "type": "DRUG" }, { "name": "Endoscopic Sinus Surgery", "type": "PROCEDURE" }, { "name": "Blood sampling for hematology", "type": "PROCEDURE" }, { "name": "Blood sampling for plasma chemistry profile", "type": "PROCEDURE" }, { "name": "Serum pregnancy test (for women of child-bearing potential)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2005-11", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2011-04-21", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 18, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Hoover, Alabama + 11 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00232154" }, { "nct_id": "NCT04852029", "title": "Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infertility, Female" ], "interventions": [ { "name": "Low dose hCG", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Reproductive Medicine Associates of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "46 Years", "sex": "FEMALE", "summary": "18 Years to 46 Years · Female only" }, "enrollment_count": 12, "start_date": "2021-08-16", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2022-01-28", "last_synced_at": "2026-09-02T09:22:37.144Z", "location_count": 1, "location_summary": "Basking Ridge, New Jersey", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04852029" } ] }